SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-080393
Filing Date
2012-11-28
Accepted
2012-11-28 12:31:17
Documents
15
Period of Report
2012-11-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-28173_18k.htm 8-K 27575
2 EX-99.1 a12-28173_1ex99d1.htm EX-99.1 19040
3 GRAPHIC g281731mmi001.gif GRAPHIC 192764
4 GRAPHIC g281731mmi002.gif GRAPHIC 80505
5 GRAPHIC g281731mmi003.gif GRAPHIC 15312
6 GRAPHIC g281731mmi004.jpg GRAPHIC 56296
7 GRAPHIC g281731mmi005.gif GRAPHIC 35080
8 GRAPHIC g281731mmi006.gif GRAPHIC 36010
9 GRAPHIC g281731mmi007.jpg GRAPHIC 49333
10 GRAPHIC g281731mmi008.jpg GRAPHIC 49153
11 GRAPHIC g281731mmi009.gif GRAPHIC 35841
12 GRAPHIC g281731mmi010.gif GRAPHIC 35628
13 GRAPHIC g281731mmi011.gif GRAPHIC 27286
14 GRAPHIC g281731mmi012.jpg GRAPHIC 59522
15 GRAPHIC g281731mmi013.gif GRAPHIC 29767
  Complete submission text file 0001104659-12-080393.txt   1017566
Mailing Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703
Business Address 5001 SOUTH MIAMI BOULEVARD SUITE 300 DURHAM NC 27703 919 474 0020
TRANZYME INC (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 121228301
SIC: 2834 Pharmaceutical Preparations